Since BAs are farnesoid X receptor (Fxr) agonists, which can interact with MAPKs and NF-κB signaling [24,25,26], the impacts of ALS on the activation of FXR and its downstream small heterodimer partner (Shp) in the colon was further examined. This evidence concerns the gene NFKB1 and amyotrophic lateral sclerosis.